Table 4. Multivariable-adjusted binary logistic analysis of predicting LV remodeling at 6 months.
| Variable | Odds ratio (95% CI) | P value |
|---|---|---|
| Model 1 (clinical factors) | ||
| logNT-proBNP | 6.243 (2.158–18.060) | 0.001 |
| peak CK-MB | 1.004 (1.000–1.009) | 0.040 |
| Peak Troponin T | – | 0.406 |
| Model 2 (clinical + miR-1 factors) | ||
| logNT-proBNP | 6.881 (2.305–20.541) | 0.001 |
| peak CK-MB | 1.005 (1.000–1.009) | 0.033 |
| Peak troponin T | – | 0.173 |
| miR-1 | 1.219 (1.027–1.447) | 0.024 |
| Model 3 (clinical + CMR factors) | ||
| logNT-proBNP | 5.205 (1.905–14.221) | 0.001 |
| Peak troponin T | – | 0.548 |
| peak CK-MB | – | 0.090 |
| Infarct size (%LV) | – | 0.062 |
| Area at risk (%LV) | – | 0.310 |
| GLS (%) | – | 0.058 |
| ECV (%LV) | 1.171 (1.017–1.349) | 0.028 |
| Model 4 (clinical + miR-1 + CMR factors) | ||
| logNT-proBNP | 7.015 (2.058–23.915) | 0.002 |
| Peak troponin T | – | 0.263 |
| peak CK-MB | – | 0.163 |
| miR-1 | 1.494 (1.167–1.914) | 0.001 |
| Infarct size (%LV) | 1.080 (1.005–1.161) | 0.036 |
| Area at risk (%LV) | – | 0.683 |
| GLS (%) | – | 0.093 |
| ECV (%LV) | 1.333 (1.089–1.631) | 0.005 |
NT-proBNP, N-terminal pro-brain natriuretic peptide; CK-MB, creatine kinase-MB; GLS, global longitudinal strain; LV, left ventricular; ECV, extracellular volume.